Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides

Life Sciences

Volumn 83, Issue 11-12, 2008, Pages 421-425

  Karamyan, Vardan T ^a   Stockmeier, Craig A ^b,c   Speth, Robert C ^a,d  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Angiotensin receptors; Brain angiotensin system; Gender; Parachloromercuribenzoate; Radioligand binding; Thiols

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINASE; BENZOIC ACID DERIVATIVE; ISOLEUCINE; LOSARTAN; NEUROPEPTIDE; PARACHLOROMERCURIBENZOATE; RADIOLIGAND; SARCOSINE; SARCOSINE I 125; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; FEMALE; HUMAN; HUMAN TISSUE; MALE; ORGAN WEIGHT; PROTEIN BINDING; RECEPTOR AFFINITY; RODENT; SEX DIFFERENCE; TEMPORAL CORTEX;

1-SARCOSINE-8-ISOLEUCINE ANGIOTENSIN II; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINS; BINDING SITES; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CEREBRAL CORTEX; FEMALE; HUMANS; IMIDAZOLES; LIGANDS; LOSARTAN; MALE; MIDDLE AGED; P-CHLOROMERCURIBENZOIC ACID; PEPTIDES; PROTEASE INHIBITORS; PYRIDINES; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SEX CHARACTERISTICS;

RODENTIA;

EID: 50849119066     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.003     Document Type: Article

References (50)

1. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., and Chai S.Y. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. Journal of Biological Chemistry 276 (2001) 48623-48626
2. Allen A.M., MacGregor D.P., Chai S.Y., Donnan G.A., Kaczmarczyk S., Richardson K., Kalnins R., Ireton J., and Mendelsohn F.A. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Annals of Neurology 32 (1992) 339-344
3. Anand-Srivastava M.B., and Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacological Reviews 45 (1993) 455-497
4. Barford D. The role of cysteine residues as redox-sensitive regulatory switches. Current Opinion in Structural Biology 14 (2004) 679-686
5. Barnes J.M., Steward L.J., Barber P.C., and Barnes N.M. Identification and characterisation of angiotensin II receptor subtypes in human brain. European Journal of Pharmacology 230 (1993) 251-258
6. Brownfield M.S., Reid I.A., Ganten D., and Ganong W.F. Differential distribution of immunoreactive angiotensin and angiotensin converting enzyme in rat brain. Neuroscience 7 (1982) 1759-1769
7. Chai S.Y., Fernando R., Peck G., Ye S.Y., Mendelsohn F.A., Jenkins T.A., and Albiston A.L. The angiotensin IV/AT4 receptor. Cellular and Molecular Life Sciences 61 (2004) 2728-2737
8. Chappell M.C. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?. Hypertension 50 (2007) 596-599
9. Chiu A.T., McCall D.E., Nguyen T.T., Carini D.J., Duncia J.V., Herblin W.F., Uyeda R.T., Wong P.C., Wexler R.R., Johnson A.L., and Timmermans P.B.M.W.M. Discrimination of angiotensin II receptor subtypes by dithiothreitol. European Journal of Pharmacology 170 (1989) 117-118
10. Civelli O. Functional genomics: the search for novel neurotransmitters and neuropeptides. FEBS Letters 430 (1998) 55-58
11. Dampney R.A., Coleman M.J., Fontes M.A., Hirooka Y., Horiuchi J., Li Y.W., Polson J.W., Potts P.D., and Tagawa T. Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clinical and Experimental Pharmacology and Physiology 29 (2002) 261-268
12. Doobay M.F., Talman L.S., Obr T.D., Tian X., Davisson R.L., and Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 292 (2007) R373-R381
13. Fitzsimons J.T. Angiotensin, thirst, and sodium appetite. Physiological Reviews 78 (1998) 583-686
14. Ge J.A., and Barnes N.M. Alterations in angiotensin AT(1) and AT(2) receptor subtype levels in brain regions from patients with neurodegenerative disorders. European Journal of Pharmacology 297 (1996) 299-306
15. Gehlert D.R., Gackenheimer S.L., and Schober D.A. Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2. Brain Research 546 (1991) 161-165
16. Hagiwara H., Sugiura N., Wakita K., and Hirose S. Purification and characterization of angiotensin-binding protein from porcine liver cytosolic fraction. European Journal of Biochemistry 185 (1989) 405-410
17. Harding J.W., Cook V.I., Miller-Wing A.V., Hanesworth J.M., Sardinia M.F., Hall K.L., Stobb J.W., Swanson G.N., Coleman J.K., and Wright J.W. Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus. Brain Research 583 (1992) 340-343
18. Johnson A.K., and Thunhorst R.L. The neuroendocrinology of thirst and salt appetite: Visceral sensory signals and mechanisms of central integration. Frontiers in Neuroendocrinology 18 3 (1997) 292-353
19. Karamyan V.T., Gembardt F., Rabey F.M., Walther T., and Speth R.C. Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouse. European Journal of Pharmacology 590 (2008) 87-92
20. Karamyan V.T., and Speth R.C. Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain. Brain Research 1143 (2007) 83-91
21. Karamyan V.T., and Speth R.C. Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regulatory Peptides 143 (2007) 15-27
22. Karamyan V.T., Speth R.C., in press. Distribution of the Non-AT1, Non-AT2 Angiotensin-Binding Site in the Rat Brain: Preliminary Characterization. Neuroendocrinology doi:10.1159/000140635.
23. Karlin A., and Bartels E. Effects of blocking sulfhydryl groups and of reducing disulfide bonds on the acetylcholine-activated permeability system of the electroplax. Biochimica et Biophysica Acta 126 (1966) 525-535
24. Kato A., Sugiura N., Hagiwara H., and Hirose S. Cloning, amino acid sequence and tissue distribution of porcine thimet oligopeptidase. A comparison with soluble angiotensin-binding protein. European Journal of Biochemistry 221 (1994) 159-165
25. Kiron M.A., and Soffer R.L. Purification and properties of a soluble angiotensin II-binding protein from rabbit liver. Journal of Biological Chemistry 264 (1989) 4138-4142
26. Kokje R., Wilson W., Brown T., Karamyan V., Wright J., and Speth R. Pressor Actions of Aminopeptidase-Resistant Analogs of Angiotensin II in the Rat Brain: Challenging the Angiotensin III Hypothesis. Hypertension 49 (2007) 1328-1335
27. Leichert L.I., and Jakob U. Global methods to monitor the thiol-disulfide state of proteins in vivo. Antioxidant and Redox Signaling 8 (2006) 763-772
28. Lind R.W., Swanson L.W., and Ganten G. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. Neuroendocrinology 40 (1985) 2-24
29. Maack T., Suzuki M., Almeida F.A., Nussenzveig D., Scarborough R.M., McEnroe G.A., and Lewicki J.A. Physiological role of silent receptors of atrial natriuretic factor. Science 238 (1987) 675-678
30. MacGregor D.P., Murone C., and Mendelsohn F.A. The stability of angiotensin receptors and angiotensin converting enzyme in post mortem brain. Neurochemistry International 25 (1994) 413-417
31. MacGregor D.P., Murone C., Song K., Allen A.M., Paxinos G., and Mendelsohn F.A. Angiotensin II receptor subtypes in the human central nervous system. Brain Research 675 (1995) 231-240
32. McKie N., Dando P.M., Rawlings N.D., and Barrett A.J. Thimet oligopeptidase: similarity to 'soluble angiotensin II-binding protein' and some corrections to the published amino acid sequence of the rat testis enzyme. Biochemical Journal 295 (1993) 57-60
33. Osborn J.W., Fink G.D., Sved A.F., Toney G.M., and Raizada M.K. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Current Hypertension Reports 9 (2007) 228-235
34. Phillips M.I., and Sumners C. Angiotensin II in central nervous system physiology. Regulatory Peptides 78 (1998) 1-11
35. Reaux-Le Goazigo A., Iturrioz X., Fassot C., claperon C., Roques B.P., and Llorens-Cortes C. Role of angiotensin III in hypertension. Current Hypertension Reports 7 (2005) 128-134
36. Saavedra J.M. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cellular and Molecular Neurobiology 25 (2005) 485-512
37. Santos R.A., Simoes e Silva A., Maric C., Silva D.M., Machado R.P., de I B., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences, U.S.A 100 (2003) 8258-8263
38. Shrimpton C.N., Abbenante G., Lew R.A., and Smith I. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15. Biochemical Journal 345 (2000) 351-356 Pt 2
39. Smith A.I., Lew R.A., Shrimpton C.N., Evans R.G., and Abbenante G. A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension. Hypertension 35 (2000) 626-630
40. Speth R.C., and Harding J.W. Radiolabeling of Angiotensin Peptides. In: Wang D.H. (Ed). Angiotensin Protocols (2001), Humana Press, Totowa, NJ 275-295
41. Speth R.C., and Karamyan V.T. The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Failure Reviews 13 (2008) 299-309
42. Speth R.C., Rowe B.P., Grove K.L., Carter M.R., and Saylor D.L. Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain. Brain Research 548 (1991) 1-8
43. Stornetta R.L., Hawelu-Johnson C.L., Guyenet P.G., and Lynch K.R. Astrocytes synthesize angiotensinogen in brain. Science 242 (1988) 1444-1446
44. Takeda S., Sato N., Ogihara T., and Morishita R. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential. Frontiers in Bioscience 13 (2008) 2253-2265
45. Veerasingham S.J., and Raizada M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. British Journal of Pharmacology 139 (2003) 191-202
46. Williams H.C., and Griendling K.K. NADPH oxidase inhibitors: new antihypertensive agents?. Journal of Cardiovascular Pharmacology 50 (2007) 9-16
47. Wright J.W., and Harding J.W. Brain angiotensin receptor subtypes AT(1), AT(2), and AT(4) and their functions. Regulatory Peptides 59 (1995) 269-295
48. Wright J.W., Krebs L.T., Stobb J.W., and Harding J.W. The angiotensin IV system: functional implications. Frontiers in Neuroendocrinology 16 (1995) 23-52
49. Ying J., Clavreul N., Sethuraman M., Adachi T., and Cohen R.A. Thiol oxidation in signaling and response to stress: detection and quantification of physiological and pathophysiological thiol modifications. Free Radical Biology in Medicine 43 (2007) 1099-1108
50. Zimmerman M.C., and Davisson R.L. Redox signaling in central neural regulation of cardiovascular function. Progress in Biophysics and Molecular Biology 84 (2004) 125-149